The global Electronic Trial Master File (eTMF) Systems market garnered revenue around USD XX Billion in 2019 and projected to reach USD 2 Billion in 2027, with at a compound annual growth rate of 13.20% throughout the estimate period from 2020 to 2027.
The pharmaceutical, as well as the biotechnology companies, face a major challenge to maintain a central repository for the storage of clinical trial documents for use in regulatory submissions. Therefore, there emerges a need to store all the data produced by these companies effectively. As a result, software companies have developed electronic trial master file systems that aid these companies as well as the contract research organizations in systemized storage of files. Moreover, in comparison to the traditional storage systems, electronic trial master file systems facilitate content classification and easier interoperability in clinical trial operations.
Increasing government funding to support clinical trials
High investment in research and development by pharmaceutical and biotechnology companies
Adherence to compliance of IT in the pharmaceutical sector
Concerns regarding clinical data privacy
The dearth of skilled professionals for the operation of electronic trial master file systems
Changing the regulatory landscape in developing and underdeveloped countries
This research report encompasses precise assessment of the market with the help of comprehensive qualitative insights and supportable prognoses regarding market size, consumption and production. The projections presented in the report have been derived using proven research methodologies and assumptions. It does so by means of comprehensive qualitative insights, historical statistics, and verifiable predictions about market revenue and sales.
The rapidly budding threat owed to the eruption of COVID-19 is impacting lives, communities, businesses, and industries across the globe. With businesses shuttered, flights grounded, COVID-19 is about to affect the global economy in different ways such as by directly upsetting production and demand, by generating supply chain disruption, and by its financial impact on firms and financial markets. Therefore, this report covers COVID-19 outbreak impact analysis on the Electronic Trial Master File (eTMF) Systems market under the research study. The market estimates offered in the report are the outcome of in-depth extensive secondary research, primary interviews and in-house professional assessments. These market evaluations have been measured by reviewing the impact of numerous social, political and economic factors coupled with recent market dynamics affecting the Electronic Trial Master File (eTMF) Systems market growth.
The global Electronic Trial Master File (eTMF) Systems market is characterized by the presence of numerous small as well as medium scale companies. These players are largely focused towards forward integration via raw material production, product manufacturing, and distribution across various industry verticals. The report recognizes numerous crucial manufacturers of the market. This research study aids to comprehend the strategies and associations that companies are converging to survive in this competitive marketplace. This report assists in understanding footprints of the manufacturers with the help of their global revenue, production, capacity and average selling price analysis for period 2016-2027.
Major manufacturers analysed under this study comprises:
Aurea, Inc. (US)
Covance Inc. (US)
ePharmaSolutions (US)
MasterControl, Inc. (US)
Oracle (US)
Phlexglobal (US)
SureClinical Inc. (US)
TransPerfect (US)
Veeva Systems (US)
Wingspan (IQVIA) (US)
This report delivers market breakdown and its revenue, consumption, production analysis and projections by categorizing it depending on parameters such as type, application/end-user, and region. This research report delivers the analysis and prognosis of revenue, production, price, market share and growth trend for different products such as:
By Component
Software
Services
Deployment Mode
Cloud/Web-Based
On-Premise
End User
Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Others
Regional Analysis and Forecast
Further, this research study analyses market size, production, consumption and its advancement trends at global, regional, and country level for period 2016 to 2027 and covers following region in its scope:
North America
? U.S.
? Canada
Europe
? Germany
? U.K.
? Italy
? France
? Rest of EU
Asia Pacific
? China
? India
? Japan
? Southeast Asia
? Rest of APAC
Central & South America
? Brazil
? Argentina
? Rest of Central & South America
Middle East and Africa
? UAE
? Saudi Arabia
? Rest of MEA
Request Customization
Get a Sample
Get a Sample
Request Customization